Tiziana Life Sciences Ltd
TLSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723069
No open-market purchases or sales by Tiziana Life Sciences Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q3 2026, worth $4.43M in total; no superinvestor holds it.
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports Tiziana Life Sciences Ltd filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
| Filed | Form | 8-K items | Period | Document | Filing index |
|---|---|---|---|---|---|
| May 1, 2026 | 20-F | – | Dec 31, 2025 | SEC | Index |
| May 8, 2025 | 20-F/A | – | Dec 31, 2024 | SEC | Index |
| May 6, 2025 | 20-F | – | Dec 31, 2024 | SEC | Index |
| May 10, 2024 | 20-F | – | Dec 31, 2023 | SEC | Index |
| Jun 13, 2023 | 20-F/A | – | Dec 31, 2022 | SEC | Index |
| Apr 26, 2023 | 20-F | – | Dec 31, 2022 | SEC | Index |
| May 23, 2022 | 20-F | – | Dec 31, 2021 | SEC | Index |
| May 17, 2021 | 20-F | – | Dec 31, 2020 | SEC | Index |
| Jun 17, 2020 | 20-F | – | Dec 31, 2019 | SEC | Index |
| Apr 4, 2019 | 20-F | – | Dec 31, 2018 | SEC | Index |